DK142802B - Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. - Google Patents

Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. Download PDF

Info

Publication number
DK142802B
DK142802B DK97875AA DK97875A DK142802B DK 142802 B DK142802 B DK 142802B DK 97875A A DK97875A A DK 97875AA DK 97875 A DK97875 A DK 97875A DK 142802 B DK142802 B DK 142802B
Authority
DK
Denmark
Prior art keywords
stomach
parts
coated
preparation
gastric juice
Prior art date
Application number
DK97875AA
Other languages
Danish (da)
English (en)
Other versions
DK97875A (zh
DK142802C (zh
Inventor
Sumio Watanabe
Masanori Kayano
Yoshio Ishino
Kohei Miyao
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of DK97875A publication Critical patent/DK97875A/da
Publication of DK142802B publication Critical patent/DK142802B/da
Application granted granted Critical
Publication of DK142802C publication Critical patent/DK142802C/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus

Landscapes

  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
DK97875AA 1974-03-12 1975-03-11 Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken. DK142802B (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2767374A JPS5512411B2 (zh) 1974-03-12 1974-03-12
JP2767374 1974-03-12

Publications (3)

Publication Number Publication Date
DK97875A DK97875A (zh) 1975-09-13
DK142802B true DK142802B (da) 1981-02-02
DK142802C DK142802C (zh) 1981-09-21

Family

ID=12227459

Family Applications (1)

Application Number Title Priority Date Filing Date
DK97875AA DK142802B (da) 1974-03-12 1975-03-11 Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken.

Country Status (12)

Country Link
US (1) US3976764A (zh)
JP (1) JPS5512411B2 (zh)
BE (1) BE826498A (zh)
CA (1) CA1054056A (zh)
CH (1) CH604719A5 (zh)
DE (1) DE2510620C2 (zh)
DK (1) DK142802B (zh)
ES (1) ES435500A1 (zh)
FR (1) FR2263744B1 (zh)
GB (1) GB1507521A (zh)
NL (1) NL7502952A (zh)
SE (1) SE409286B (zh)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003437A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form

Families Citing this family (60)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH630257A5 (en) * 1975-03-17 1982-06-15 Hoffmann La Roche Sustained release formulation
US4167558A (en) * 1976-02-13 1979-09-11 Hoffmann-La Roche Inc. Novel sustained release tablet formulations
US4140755A (en) * 1976-02-13 1979-02-20 Hoffmann-La Roche Inc. Sustained release tablet formulations
US4207890A (en) * 1977-01-04 1980-06-17 Mcneilab, Inc. Drug-dispensing device and method
JPS6024767B2 (ja) * 1979-08-24 1985-06-14 塩野義製薬株式会社 腸溶性硬カプセル剤
JPS58501128A (ja) * 1981-07-15 1983-07-14 キイ・フア−マシユ−テイカルズ・インコ−ポレイテツド 徐放性テオフイリン
US4451260A (en) * 1982-03-26 1984-05-29 Minnesota Mining And Manufacturing Company Sustained release oral medicinal delivery device
JPS5953410A (ja) * 1982-09-20 1984-03-28 Fujisawa Pharmaceut Co Ltd 新型ソフトカプセル剤
JPS59193831A (ja) * 1983-04-18 1984-11-02 Sankyo Co Ltd 腸溶性製剤の製造法
US4505890A (en) * 1983-06-30 1985-03-19 E. R. Squibb & Sons, Inc. Controlled release formulation and method
SE457505B (sv) * 1984-01-10 1989-01-09 Lejus Medical Ab Laminatbelagd oral farmaceutisk komposition och foerfarande foer dess framstaellning
US4610870A (en) * 1984-10-05 1986-09-09 E. R. Squibb & Sons, Inc. Controlled release formulation
JPS61107782U (zh) * 1984-12-19 1986-07-08
US4735804A (en) * 1985-05-10 1988-04-05 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4758436A (en) * 1985-05-29 1988-07-19 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4767627A (en) * 1985-05-29 1988-08-30 Merck & Co., Inc. Drug delivery device which can be retained in the stomach for a controlled period of time
US4666705A (en) * 1985-06-03 1987-05-19 E. R. Squibb & Sons, Inc. Controlled release formulation
US4756911A (en) * 1986-04-16 1988-07-12 E. R. Squibb & Sons, Inc. Controlled release formulation
US4814178A (en) * 1987-07-01 1989-03-21 Sanford Bolton Floating sustained release therapeutic compositions
DE3803482A1 (de) * 1988-02-05 1989-08-17 Lohmann Therapie Syst Lts Schwimmfaehiges orales therapeutisches system
JPH082781B2 (ja) * 1988-10-18 1996-01-17 嘉明 川島 中空顆粒状医薬及びその製法
CA2085585A1 (en) * 1990-06-25 1991-12-26 George Torosian Amantadine hydrochloride suspension with enhanced dissolution characteristics for use in soft gelatin capsules
US5232704A (en) * 1990-12-19 1993-08-03 G. D. Searle & Co. Sustained release, bilayer buoyant dosage form
US5198229A (en) * 1991-06-05 1993-03-30 Alza Corporation Self-retaining gastrointestinal delivery device
US5314696A (en) * 1991-06-27 1994-05-24 Paulos Manley A Methods for making and administering a blinded oral dosage form and blinded oral dosage form therefor
DE4406424A1 (de) 1994-02-28 1995-08-31 Bayer Ag Expandierbare Arzneiformen
JP2671257B2 (ja) * 1995-07-13 1997-10-29 エーザイ株式会社 溶解遅延性ゼラチン製剤組成物
SE9702533D0 (sv) 1997-07-01 1997-07-01 Astra Ab New oral formulation
IN186245B (zh) 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
CN1203846C (zh) 1998-03-19 2005-06-01 布里斯托尔-迈尔斯斯奎布公司 高溶解性药物的双相控释递送系统和方法
EP1245227A1 (en) * 2001-03-31 2002-10-02 Jagotec Ag A pharmaceutical tablet system that floats in the stomach for programmed release of active substance and process of producing buoyant material contained in same
US20030203027A1 (en) * 2002-04-26 2003-10-30 Ethicon, Inc. Coating technique for deposition of drug substance on a substrate
US20040086566A1 (en) * 2002-11-04 2004-05-06 Alpharma, Inc. Waxy matrix dosage forms
US7485322B2 (en) * 2002-12-24 2009-02-03 Lek Pharmaceuticals D.D. Modified release pharmaceutical composition
SI1596841T1 (sl) * 2003-02-21 2009-06-30 Lek Pharmaceuticals D.D. Terapevtski sistem amoksicilina in klavulanske kisline
AU2004289221B2 (en) * 2003-11-04 2009-12-17 Supernus Pharmaceuticals, Inc Sustained release of positively charged pharmacologically active molecules from a matrix containing polymers with polarized oxygen atoms
BRPI0716481A2 (pt) * 2006-09-04 2014-03-18 Panacea Biotec Ltd Tecnologia de liberação flutuante programável
WO2009087665A2 (en) * 2007-12-11 2009-07-16 Vishwanath Sudhir Nande Novel gastroretentive drug delivery system
GB2460915B (en) 2008-06-16 2011-05-25 Biovascular Inc Controlled release compositions of agents that reduce circulating levels of platelets and methods therefor
JP2012500230A (ja) * 2008-08-18 2012-01-05 北京天衡▲薬▼物研究院 胃内滞留薬物放出システム及びその製造方法と使用
FR2945945B1 (fr) * 2009-05-29 2011-07-29 Flamel Tech Sa Procede de preparation de particules creuses et leurs applications
FR2945947B1 (fr) 2009-05-29 2011-07-29 Flamel Tech Sa Compositions pharmaceutiques flottantes a liberation controlee
US20120100212A1 (en) * 2009-07-06 2012-04-26 Kyorin Pharmaceutical, Co., Ltd. Tablet having hollow structure
WO2012004231A1 (en) * 2010-07-05 2012-01-12 Jagotec Ag Dosage form
EP2731609A1 (en) * 2011-07-14 2014-05-21 APeT Holding B.V. Nicotinamide compositions and the therapeutic use thereof
AU2012322323B2 (en) 2011-10-11 2016-04-21 Sun Pharmaceutical Industries Limited A gastroretentive dosage system and process of preparation thereof
CA3149459A1 (en) * 2012-07-16 2014-01-23 APET Holding B.V. Gastro-retentive drug delivery system
EP2719376B1 (en) 2012-10-12 2015-03-04 Omya International AG Gastroretentive drug formulation and delivery systems and their method of preparation using functionalized calcium carbonate
US20170266112A1 (en) 2014-06-11 2017-09-21 Massachusetts Institute Of Technology Residence structures and related methods
EP3155024B1 (en) 2014-06-11 2020-09-16 Massachusetts Institute Of Technology Residence structures and related methods
EP3034070A1 (en) 2014-12-18 2016-06-22 Omya International AG Method for the production of a pharmaceutical delivery system
CN104706613B (zh) * 2015-03-20 2018-01-16 华侨大学 一种胃漂浮空心缓释片的制备方法
EP3069713A1 (en) 2015-03-20 2016-09-21 Omya International AG Dispersible dosage form
CA2983272C (en) 2015-05-01 2023-08-29 Massachusetts Institute Of Technology Triggerable shape memory induction devices
JP7085473B2 (ja) 2015-10-23 2022-06-16 リンドラ セラピューティクス， インコーポレイティド 治療薬の持続放出用の胃内滞留システム及びその使用方法
KR20180090881A (ko) 2015-12-08 2018-08-13 린드라 인코퍼레이티드 위 체류 시스템을 위한 기하 구성형태
EP3429556A1 (en) * 2016-03-18 2019-01-23 Grünenthal GmbH Floating pharmaceutical dosage form
EP3269361A1 (en) 2016-07-14 2018-01-17 Omya International AG Dosage form
US11576866B2 (en) 2016-09-30 2023-02-14 Lyndra Therapeutics, Inc. Gastric residence systems for sustained delivery of adamantane-class drugs
WO2023166225A1 (en) * 2022-03-04 2023-09-07 APET Holding B.V. Digestive enzyme formulations

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3418999A (en) * 1964-02-12 1968-12-31 Donald W. Davis Method of swallowing a pill
FR1454013A (fr) * 1965-08-18 1966-07-22 Pluripharm Mode de présentation de deux médicaments associés
US3870790A (en) * 1970-01-22 1975-03-11 Forest Laboratories Solid pharmaceutical formulations containing hydroxypropyl methyl cellulose

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1985003437A1 (en) * 1984-02-10 1985-08-15 A/S Alfred Benzon Diffusion coated multiple-units dosage form

Also Published As

Publication number Publication date
CH604719A5 (zh) 1978-09-15
NL7502952A (nl) 1975-09-16
DE2510620A1 (de) 1975-09-18
SE409286B (sv) 1979-08-13
CA1054056A (en) 1979-05-08
JPS50121418A (zh) 1975-09-23
ES435500A1 (es) 1977-02-01
JPS5512411B2 (zh) 1980-04-02
DK97875A (zh) 1975-09-13
SE7502725L (zh) 1975-09-15
US3976764A (en) 1976-08-24
FR2263744B1 (zh) 1978-11-24
DK142802C (zh) 1981-09-21
BE826498A (fr) 1975-06-30
DE2510620C2 (de) 1984-01-05
GB1507521A (en) 1978-04-19
FR2263744A1 (zh) 1975-10-10

Similar Documents

Publication Publication Date Title
DK142802B (da) Fremgangsmåde til fremstilling af terapeutiske præparater til indføring i mavesækken.
EP0235718B1 (en) Granule remaining in stomach
FI78835C (fi) Foerfarande foer framstaellning av en ny dipyridamol-retardform.
US2928770A (en) Sustained action pill
CA2342340C (en) New sustained release oral formulations
BE1004882A3 (fr) Forme posologique pharmaceutique solide orale a liberation programmee.
RU2477126C2 (ru) Глюкозинолаты и бета-тиоглюкозидазы, покрытые энтеросолюбильной оболочкой
US4587118A (en) Dry sustained release theophylline oral formulation
US4935247A (en) Composition for the oral administration of pharmaceuticals
BG63152B1 (bg) Дозирани форми с контролирано освобождаване на азитромицин
GB2101484A (en) Oral dipyridamole compositions
DK151608B (da) Fremgangsmaade til fremstilling af et farmaceutisk peroralt polydepotpraeparat med kontrolleret afgivelse
PL188834B1 (pl) Farmaceutyczne formulacje zawierające tramadol lub jego fizjologicznie akceptowane sole oraz sposóbwytwarzania tych formulacji
JPH0256418A (ja) 新規医薬製剤およびその製造方法
AU2018202652A1 (en) Gastro-retentive drug delivery system
Gohel Modulation of active pharmaceutical material release from a novel ‘tablet in capsule system’containing an effervescent blend
WO2001024777A1 (en) Coated solid dosage forms
EP0425699B1 (en) Oral preparation which can be released at suitable region in intestine
JPH0624962A (ja) 腸溶徐放性製剤
CN105377247A (zh) 用于治疗溃疡性结肠炎含磷脂酰胆碱的药物制剂
WO2020060426A1 (en) An oral preparation containing sodium butyrate
AU684786B2 (en) A drug delivery composition for alpha-adreno receptor blocking agents
CA2533178C (en) Antibiotic product, use and formulation thereof
CA2644699A1 (en) Oral pharmaceutical coated composition for pulsatile release
JPS6322014A (ja) 胃内浮遊性持続型カプセル剤

Legal Events

Date Code Title Description
PBP Patent lapsed